Global Drugs Based on CAR T-cell Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Description

According to our (Global Info Research) latest study, the global Drugs Based on CAR T-cell market size was valued at USD 2887 million in 2023 and is forecast to a readjusted size of USD 16810 million by 2030 with a CAGR of 28.6% during review period.

Chimeric antigen receptor (CAR) T-cell therapy is a way to get immune cells called T cells (a type of white blood cell) to fight cancer by changing them in the lab so they can find and destroy cancer cells. CAR T-cell therapy is also sometimes talked about as a type of cell-based gene therapy, because it involves altering the genes inside T cells to help them attack the cancer
The CAR T-cell therapy drug gel market is driven by the revolutionary approach of CAR T-cell therapy in cancer treatment and the demand for targeted and personalized therapies. CAR T-cell therapy involves genetically modifying a patient's own T cells to target and destroy cancer cells. The rise in cancer prevalence and the need for innovative treatments contribute to market growth as healthcare providers seek effective and tailored solutions for patients with difficult-to-treat cancers. Moreover, advancements in gel-based drug delivery systems have improved the precision and safety of CAR T-cell therapy administration. However, the market also faces challenges, including complex manufacturing processes and potential side effects associated with immune response. Additionally, addressing the high cost of CAR T-cell therapies and ensuring scalability and accessibility for broader patient populations can pose obstacles for manufacturers and healthcare systems. To succeed, companies must focus on advancing research and development, collaborating with oncologists to optimize therapy protocols, and addressing the challenges to meet the increasing demand for breakthrough cancer treatments.

The Global Info Research report includes an overview of the development of the Drugs Based on CAR T-cell industry chain, the market status of Lymphoma (CD19-targeted, BCMA-targeted), Multiple Myeloma (CD19-targeted, BCMA-targeted), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Drugs Based on CAR T-cell.

Regionally, the report analyzes the Drugs Based on CAR T-cell markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Drugs Based on CAR T-cell market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Drugs Based on CAR T-cell market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Drugs Based on CAR T-cell industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CD19-targeted, BCMA-targeted).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Drugs Based on CAR T-cell market.

Regional Analysis: The report involves examining the Drugs Based on CAR T-cell market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Drugs Based on CAR T-cell market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Drugs Based on CAR T-cell:
Company Analysis: Report covers individual Drugs Based on CAR T-cell players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Drugs Based on CAR T-cell This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Lymphoma, Multiple Myeloma).

Technology Analysis: Report covers specific technologies relevant to Drugs Based on CAR T-cell. It assesses the current state, advancements, and potential future developments in Drugs Based on CAR T-cell areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Drugs Based on CAR T-cell market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Drugs Based on CAR T-cell market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
    CD19-targeted
    BCMA-targeted

Market segment by Application
    Lymphoma
    Multiple Myeloma

Market segment by players, this report covers
    Novartis
    Gilead Sciences
    Bristol-Myers Squibb
    J & J
    JW Therapeutics
    FOSUNKite

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Drugs Based on CAR T-cell product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Drugs Based on CAR T-cell, with revenue, gross margin and global market share of Drugs Based on CAR T-cell from 2019 to 2024.
Chapter 3, the Drugs Based on CAR T-cell competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Drugs Based on CAR T-cell market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drugs Based on CAR T-cell.
Chapter 13, to describe Drugs Based on CAR T-cell research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Drugs Based on CAR T-cell
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Drugs Based on CAR T-cell by Type
        1.3.1 Overview: Global Drugs Based on CAR T-cell Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Drugs Based on CAR T-cell Consumption Value Market Share by Type in 2023
        1.3.3 CD19-targeted
        1.3.4 BCMA-targeted
    1.4 Global Drugs Based on CAR T-cell Market by Application
        1.4.1 Overview: Global Drugs Based on CAR T-cell Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Lymphoma
        1.4.3 Multiple Myeloma
    1.5 Global Drugs Based on CAR T-cell Market Size & Forecast
    1.6 Global Drugs Based on CAR T-cell Market Size and Forecast by Region
        1.6.1 Global Drugs Based on CAR T-cell Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Drugs Based on CAR T-cell Market Size by Region, (2019-2030)
        1.6.3 North America Drugs Based on CAR T-cell Market Size and Prospect (2019-2030)
        1.6.4 Europe Drugs Based on CAR T-cell Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Drugs Based on CAR T-cell Market Size and Prospect (2019-2030)
        1.6.6 South America Drugs Based on CAR T-cell Market Size and Prospect (2019-2030)
        1.6.7 Middle East and Africa Drugs Based on CAR T-cell Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Novartis
        2.1.1 Novartis Details
        2.1.2 Novartis Major Business
        2.1.3 Novartis Drugs Based on CAR T-cell Product and Solutions
        2.1.4 Novartis Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Novartis Recent Developments and Future Plans
    2.2 Gilead Sciences
        2.2.1 Gilead Sciences Details
        2.2.2 Gilead Sciences Major Business
        2.2.3 Gilead Sciences Drugs Based on CAR T-cell Product and Solutions
        2.2.4 Gilead Sciences Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Gilead Sciences Recent Developments and Future Plans
    2.3 Bristol-Myers Squibb
        2.3.1 Bristol-Myers Squibb Details
        2.3.2 Bristol-Myers Squibb Major Business
        2.3.3 Bristol-Myers Squibb Drugs Based on CAR T-cell Product and Solutions
        2.3.4 Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.4 J & J
        2.4.1 J & J Details
        2.4.2 J & J Major Business
        2.4.3 J & J Drugs Based on CAR T-cell Product and Solutions
        2.4.4 J & J Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 J & J Recent Developments and Future Plans
    2.5 JW Therapeutics
        2.5.1 JW Therapeutics Details
        2.5.2 JW Therapeutics Major Business
        2.5.3 JW Therapeutics Drugs Based on CAR T-cell Product and Solutions
        2.5.4 JW Therapeutics Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 JW Therapeutics Recent Developments and Future Plans
    2.6 FOSUNKite
        2.6.1 FOSUNKite Details
        2.6.2 FOSUNKite Major Business
        2.6.3 FOSUNKite Drugs Based on CAR T-cell Product and Solutions
        2.6.4 FOSUNKite Drugs Based on CAR T-cell Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 FOSUNKite Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Drugs Based on CAR T-cell Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Drugs Based on CAR T-cell by Company Revenue
        3.2.2 Top 3 Drugs Based on CAR T-cell Players Market Share in 2023
        3.2.3 Top 6 Drugs Based on CAR T-cell Players Market Share in 2023
    3.3 Drugs Based on CAR T-cell Market: Overall Company Footprint Analysis
        3.3.1 Drugs Based on CAR T-cell Market: Region Footprint
        3.3.2 Drugs Based on CAR T-cell Market: Company Product Type Footprint
        3.3.3 Drugs Based on CAR T-cell Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Drugs Based on CAR T-cell Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Drugs Based on CAR T-cell Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Drugs Based on CAR T-cell Consumption Value Market Share by Application (2019-2024)
    5.2 Global Drugs Based on CAR T-cell Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Drugs Based on CAR T-cell Consumption Value by Type (2019-2030)
    6.2 North America Drugs Based on CAR T-cell Consumption Value by Application (2019-2030)
    6.3 North America Drugs Based on CAR T-cell Market Size by Country
        6.3.1 North America Drugs Based on CAR T-cell Consumption Value by Country (2019-2030)
        6.3.2 United States Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        6.3.3 Canada Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        6.3.4 Mexico Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Drugs Based on CAR T-cell Consumption Value by Type (2019-2030)
    7.2 Europe Drugs Based on CAR T-cell Consumption Value by Application (2019-2030)
    7.3 Europe Drugs Based on CAR T-cell Market Size by Country
        7.3.1 Europe Drugs Based on CAR T-cell Consumption Value by Country (2019-2030)
        7.3.2 Germany Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        7.3.3 France Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        7.3.5 Russia Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        7.3.6 Italy Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Drugs Based on CAR T-cell Market Size by Region
        8.3.1 Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Region (2019-2030)
        8.3.2 China Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        8.3.3 Japan Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        8.3.4 South Korea Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        8.3.5 India Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        8.3.7 Australia Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Drugs Based on CAR T-cell Consumption Value by Type (2019-2030)
    9.2 South America Drugs Based on CAR T-cell Consumption Value by Application (2019-2030)
    9.3 South America Drugs Based on CAR T-cell Market Size by Country
        9.3.1 South America Drugs Based on CAR T-cell Consumption Value by Country (2019-2030)
        9.3.2 Brazil Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        9.3.3 Argentina Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Drugs Based on CAR T-cell Market Size by Country
        10.3.1 Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Country (2019-2030)
        10.3.2 Turkey Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)
        10.3.4 UAE Drugs Based on CAR T-cell Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Drugs Based on CAR T-cell Market Drivers
    11.2 Drugs Based on CAR T-cell Market Restraints
    11.3 Drugs Based on CAR T-cell Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Drugs Based on CAR T-cell Industry Chain
    12.2 Drugs Based on CAR T-cell Upstream Analysis
    12.3 Drugs Based on CAR T-cell Midstream Analysis
    12.4 Drugs Based on CAR T-cell Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Drugs Based on CAR T-cell Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Drugs Based on CAR T-cell Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Global Drugs Based on CAR T-cell Consumption Value by Region (2019-2024) & (USD Million)
    Table 4. Global Drugs Based on CAR T-cell Consumption Value by Region (2025-2030) & (USD Million)
    Table 5. Novartis Company Information, Head Office, and Major Competitors
    Table 6. Novartis Major Business
    Table 7. Novartis Drugs Based on CAR T-cell Product and Solutions
    Table 8. Novartis Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 9. Novartis Recent Developments and Future Plans
    Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 11. Gilead Sciences Major Business
    Table 12. Gilead Sciences Drugs Based on CAR T-cell Product and Solutions
    Table 13. Gilead Sciences Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 14. Gilead Sciences Recent Developments and Future Plans
    Table 15. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
    Table 16. Bristol-Myers Squibb Major Business
    Table 17. Bristol-Myers Squibb Drugs Based on CAR T-cell Product and Solutions
    Table 18. Bristol-Myers Squibb Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 19. Bristol-Myers Squibb Recent Developments and Future Plans
    Table 20. J & J Company Information, Head Office, and Major Competitors
    Table 21. J & J Major Business
    Table 22. J & J Drugs Based on CAR T-cell Product and Solutions
    Table 23. J & J Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 24. J & J Recent Developments and Future Plans
    Table 25. JW Therapeutics Company Information, Head Office, and Major Competitors
    Table 26. JW Therapeutics Major Business
    Table 27. JW Therapeutics Drugs Based on CAR T-cell Product and Solutions
    Table 28. JW Therapeutics Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 29. JW Therapeutics Recent Developments and Future Plans
    Table 30. FOSUNKite Company Information, Head Office, and Major Competitors
    Table 31. FOSUNKite Major Business
    Table 32. FOSUNKite Drugs Based on CAR T-cell Product and Solutions
    Table 33. FOSUNKite Drugs Based on CAR T-cell Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 34. FOSUNKite Recent Developments and Future Plans
    Table 35. Global Drugs Based on CAR T-cell Revenue (USD Million) by Players (2019-2024)
    Table 36. Global Drugs Based on CAR T-cell Revenue Share by Players (2019-2024)
    Table 37. Breakdown of Drugs Based on CAR T-cell by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 38. Market Position of Players in Drugs Based on CAR T-cell, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
    Table 39. Head Office of Key Drugs Based on CAR T-cell Players
    Table 40. Drugs Based on CAR T-cell Market: Company Product Type Footprint
    Table 41. Drugs Based on CAR T-cell Market: Company Product Application Footprint
    Table 42. Drugs Based on CAR T-cell New Market Entrants and Barriers to Market Entry
    Table 43. Drugs Based on CAR T-cell Mergers, Acquisition, Agreements, and Collaborations
    Table 44. Global Drugs Based on CAR T-cell Consumption Value (USD Million) by Type (2019-2024)
    Table 45. Global Drugs Based on CAR T-cell Consumption Value Share by Type (2019-2024)
    Table 46. Global Drugs Based on CAR T-cell Consumption Value Forecast by Type (2025-2030)
    Table 47. Global Drugs Based on CAR T-cell Consumption Value by Application (2019-2024)
    Table 48. Global Drugs Based on CAR T-cell Consumption Value Forecast by Application (2025-2030)
    Table 49. North America Drugs Based on CAR T-cell Consumption Value by Type (2019-2024) & (USD Million)
    Table 50. North America Drugs Based on CAR T-cell Consumption Value by Type (2025-2030) & (USD Million)
    Table 51. North America Drugs Based on CAR T-cell Consumption Value by Application (2019-2024) & (USD Million)
    Table 52. North America Drugs Based on CAR T-cell Consumption Value by Application (2025-2030) & (USD Million)
    Table 53. North America Drugs Based on CAR T-cell Consumption Value by Country (2019-2024) & (USD Million)
    Table 54. North America Drugs Based on CAR T-cell Consumption Value by Country (2025-2030) & (USD Million)
    Table 55. Europe Drugs Based on CAR T-cell Consumption Value by Type (2019-2024) & (USD Million)
    Table 56. Europe Drugs Based on CAR T-cell Consumption Value by Type (2025-2030) & (USD Million)
    Table 57. Europe Drugs Based on CAR T-cell Consumption Value by Application (2019-2024) & (USD Million)
    Table 58. Europe Drugs Based on CAR T-cell Consumption Value by Application (2025-2030) & (USD Million)
    Table 59. Europe Drugs Based on CAR T-cell Consumption Value by Country (2019-2024) & (USD Million)
    Table 60. Europe Drugs Based on CAR T-cell Consumption Value by Country (2025-2030) & (USD Million)
    Table 61. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Type (2019-2024) & (USD Million)
    Table 62. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Type (2025-2030) & (USD Million)
    Table 63. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Application (2019-2024) & (USD Million)
    Table 64. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Application (2025-2030) & (USD Million)
    Table 65. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Region (2019-2024) & (USD Million)
    Table 66. Asia-Pacific Drugs Based on CAR T-cell Consumption Value by Region (2025-2030) & (USD Million)
    Table 67. South America Drugs Based on CAR T-cell Consumption Value by Type (2019-2024) & (USD Million)
    Table 68. South America Drugs Based on CAR T-cell Consumption Value by Type (2025-2030) & (USD Million)
    Table 69. South America Drugs Based on CAR T-cell Consumption Value by Application (2019-2024) & (USD Million)
    Table 70. South America Drugs Based on CAR T-cell Consumption Value by Application (2025-2030) & (USD Million)
    Table 71. South America Drugs Based on CAR T-cell Consumption Value by Country (2019-2024) & (USD Million)
    Table 72. South America Drugs Based on CAR T-cell Consumption Value by Country (2025-2030) & (USD Million)
    Table 73. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Type (2019-2024) & (USD Million)
    Table 74. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Type (2025-2030) & (USD Million)
    Table 75. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Application (2019-2024) & (USD Million)
    Table 76. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Application (2025-2030) & (USD Million)
    Table 77. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Country (2019-2024) & (USD Million)
    Table 78. Middle East & Africa Drugs Based on CAR T-cell Consumption Value by Country (2025-2030) & (USD Million)
    Table 79. Drugs Based on CAR T-cell Raw Material
    Table 80. Key Suppliers of Drugs Based on CAR T-cell Raw Materials
List of Figures
    Figure 1. Drugs Based on CAR T-cell Picture
    Figure 2. Global Drugs Based on CAR T-cell Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Drugs Based on CAR T-cell Consumption Value Market Share by Type in 2023
    Figure 4. CD19-targeted
    Figure 5. BCMA-targeted
    Figure 6. Global Drugs Based on CAR T-cell Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 7. Drugs Based on CAR T-cell Consumption Value Market Share by Application in 2023
    Figure 8. Lymphoma Picture
    Figure 9. Multiple Myeloma Picture
    Figure 10. Global Drugs Based on CAR T-cell Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Drugs Based on CAR T-cell Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Market Drugs Based on CAR T-cell Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
    Figure 13. Global Drugs Based on CAR T-cell Consumption Value Market Share by Region (2019-2030)
    Figure 14. Global Drugs Based on CAR T-cell Consumption Value Market Share by Region in 2023
    Figure 15. North America Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 16. Europe Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 17. Asia-Pacific Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 18. South America Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 19. Middle East and Africa Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 20. Global Drugs Based on CAR T-cell Revenue Share by Players in 2023
    Figure 21. Drugs Based on CAR T-cell Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
    Figure 22. Global Top 3 Players Drugs Based on CAR T-cell Market Share in 2023
    Figure 23. Global Top 6 Players Drugs Based on CAR T-cell Market Share in 2023
    Figure 24. Global Drugs Based on CAR T-cell Consumption Value Share by Type (2019-2024)
    Figure 25. Global Drugs Based on CAR T-cell Market Share Forecast by Type (2025-2030)
    Figure 26. Global Drugs Based on CAR T-cell Consumption Value Share by Application (2019-2024)
    Figure 27. Global Drugs Based on CAR T-cell Market Share Forecast by Application (2025-2030)
    Figure 28. North America Drugs Based on CAR T-cell Consumption Value Market Share by Type (2019-2030)
    Figure 29. North America Drugs Based on CAR T-cell Consumption Value Market Share by Application (2019-2030)
    Figure 30. North America Drugs Based on CAR T-cell Consumption Value Market Share by Country (2019-2030)
    Figure 31. United States Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 32. Canada Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 33. Mexico Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 34. Europe Drugs Based on CAR T-cell Consumption Value Market Share by Type (2019-2030)
    Figure 35. Europe Drugs Based on CAR T-cell Consumption Value Market Share by Application (2019-2030)
    Figure 36. Europe Drugs Based on CAR T-cell Consumption Value Market Share by Country (2019-2030)
    Figure 37. Germany Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 38. France Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 39. United Kingdom Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 40. Russia Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 41. Italy Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 42. Asia-Pacific Drugs Based on CAR T-cell Consumption Value Market Share by Type (2019-2030)
    Figure 43. Asia-Pacific Drugs Based on CAR T-cell Consumption Value Market Share by Application (2019-2030)
    Figure 44. Asia-Pacific Drugs Based on CAR T-cell Consumption Value Market Share by Region (2019-2030)
    Figure 45. China Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 46. Japan Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 47. South Korea Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 48. India Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 49. Southeast Asia Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 50. Australia Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 51. South America Drugs Based on CAR T-cell Consumption Value Market Share by Type (2019-2030)
    Figure 52. South America Drugs Based on CAR T-cell Consumption Value Market Share by Application (2019-2030)
    Figure 53. South America Drugs Based on CAR T-cell Consumption Value Market Share by Country (2019-2030)
    Figure 54. Brazil Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 55. Argentina Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 56. Middle East and Africa Drugs Based on CAR T-cell Consumption Value Market Share by Type (2019-2030)
    Figure 57. Middle East and Africa Drugs Based on CAR T-cell Consumption Value Market Share by Application (2019-2030)
    Figure 58. Middle East and Africa Drugs Based on CAR T-cell Consumption Value Market Share by Country (2019-2030)
    Figure 59. Turkey Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 60. Saudi Arabia Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 61. UAE Drugs Based on CAR T-cell Consumption Value (2019-2030) & (USD Million)
    Figure 62. Drugs Based on CAR T-cell Market Drivers
    Figure 63. Drugs Based on CAR T-cell Market Restraints
    Figure 64. Drugs Based on CAR T-cell Market Trends
    Figure 65. Porters Five Forces Analysis
    Figure 66. Manufacturing Cost Structure Analysis of Drugs Based on CAR T-cell in 2023
    Figure 67. Manufacturing Process Analysis of Drugs Based on CAR T-cell
    Figure 68. Drugs Based on CAR T-cell Industrial Chain
    Figure 69. Methodology
    Figure 70. Research Process and Data Source

Companies Mentioned

Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite